Tandem Diabetes Care Inc (NASDAQ:TNDM) stock price target increased to $9.00, issued a report today by Zacks Investment Research
- Updated: October 1, 2016
In a report released on 09/29/2016 Zacks Investment Research increased the stock price target of Tandem Diabetes Care Inc (NASDAQ:TNDM) to $9.00 indicating a possible upside of 0.13%.
Previously on 9/27/2016, B. Riley reported on Tandem Diabetes Care Inc (NASDAQ:TNDM) increased the target price from $0.00 to $10.00. At the time, this indicated a possible upside of 0.23%.
Yesterday Tandem Diabetes Care Inc (NASDAQ:TNDM) traded 3.93% higher at $7.97. The company’s 50-day moving average is $7.26 and its 200-day moving average is $7.80. The last closing price is up -1.79% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time period. 123,838 shares of the stock traded hands, down from an average trading volume of 192,245
See Chart Below
Tandem Diabetes Care Inc has a 52 week low of $6.04 and a 52 week high of $12.48 The company’s market cap is currently $0.
In addition to Zacks Investment Research reporting its stock price target, a total of 8 brokers have issued a report on the company. The average stock price target is $15.84 with 5 brokers rating the stock a strong buy, 2 brokers rating the stock a buy, 3 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.
General Information About Tandem Diabetes Care Inc (NASDAQ:TNDM)
Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.